LGALS3 and COVID-19: Many markers have been studied both in the diagnosis of COVID-19 and in predicting prognosis, and Galectin-3 can be used more appropriately for clinical classification of patients rather than diagnosis. Especially low Galectin-3 levels detected in severe-critical disease groups may shed light on the timing of Galectin-3 protein-targeted therapies.